Shan Wang
Impact in
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 8
- Circular RNAs in diseases 7
- Oncology 47
- Cancer Immunotherapy and Biomarkers 8
- Cytokine Signaling Pathways and Interactions 6
- Co-authors
- Lori Frappier (3 shared papers)Guibo Sun (9 shared papers)Ying Peng (6 shared papers)Lihua Liu (4 shared papers)Jianchao Liu (4 shared papers)Yuchen Peng (4 shared papers)Changhong Xing (3 shared papers)Xiaobo Sun (4 shared papers)
- Journals
- PLoS ONE (4 papers)Frontiers in Pharmacology (3 papers)Frontiers in Oncology (3 papers)European Journal of Pharmacology (2 papers)Food Bioscience (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Shan Wang
155 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Neurology 329
- Cancer Research 449
- Molecular Biology 1.6k
- Oncology 485
- Complementary and alternative medicine 145
Countries citing papers authored by Shan Wang
This map shows the geographic impact of Shan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Wang more than expected).
Fields of papers citing papers by Shan Wang
This network shows the impact of papers produced by Shan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Wang. The network helps show where Shan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Concordance between the assessment of Aβ42, T‐tau, and P‐T181‐tau in peripheral blood neuronal‐derived exosomes and cerebrospinal fluid Hit paper breakdown → | 2019 | 283 |
| 2 | 2018 | 155 | |
| 3 | 2017 | 126 | |
| 4 | 2014 | 106 | |
| 5 | 2009 | 93 | |
| 6 | 2018 | 90 | |
| 7 | 2012 | 87 | |
| 8 | 2020 | 83 | |
| 9 | 2019 | 82 | |
| 10 | 2021 | 80 | |
| 11 | 2020 | 73 | |
| 12 | 2018 | 66 | |
| 13 | CD8+ cytotoxic and FoxP3+ regulatory T lymphocytes serve as prognostic factors in breast cancer. | 2019 | 66 |
| 14 | 2014 | 65 | |
| 15 | 2014 | 64 | |
| 16 | 2018 | 55 | |
| 17 | 2020 | 55 | |
| 18 | 2013 | 46 | |
| 19 | 2016 | 43 | |
| 20 | 2021 | 42 |
About Shan Wang
Shan Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Pulmonary and Respiratory Medicine, having authored 163 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), RNA modifications and cancer (8 papers), MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers), Computational Drug Discovery Methods (7 papers), Cytokine Signaling Pathways and Interactions (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Neurology (329 citations), Cancer Research (449 citations), Molecular Biology (1.6k citations), Oncology (485 citations) and Complementary and alternative medicine (145 citations). Shan Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Lori Frappier, Guibo Sun, Ying Peng, Lihua Liu, Jianchao Liu, Yuchen Peng, Changhong Xing, Xiaobo Sun, Y P Feng and Yong Zhang. Their work appears in journals such as PLoS ONE, Frontiers in Pharmacology, Frontiers in Oncology, European Journal of Pharmacology and Food Bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.